Latest Health News

Centaurus Metals reports strong value engineering results for its Jaguar Nickel Sulphide Project, confirming a 15-year mine life and first quartile costs, while advancing exploration at Boi Novo and Jambreiro iron ore projects.

UNITH Ltd reported a record quarterly cash receipt of $1.6 million in Q4 FY25, driven by strategic partnerships and platform innovations. The company is poised for growth with a new website launch and expanded European presence.

Greenvale Energy has initiated its first-ever drilling program at the Oasis Uranium Project in Queensland, aiming to validate and extend known uranium mineralisation with advanced techniques.

Skylark Minerals reports solid progress in its Simon Copper and Perseverance Projects with ongoing fieldwork analysis, while maintaining a strong cash position and advancing gold asset acquisitions.

Australian Foundation Investment Company Limited (AFIC) reported a $285 million net profit for FY2025, declaring a fully franked 14.5c final dividend plus a 5c special dividend tied to capital gains from portfolio adjustments.

Artrya has launched its AI-powered Salix Coronary Anatomy platform in the U.S. and submitted its Coronary Plaque module for FDA clearance, marking a key step in its commercial expansion. A new five-year contract with Tanner Health signals the start of U.S. revenues.

Global Health Limited reported a robust June quarter with a 65% rise in annual sales and a strategic pivot towards AI-driven efficiencies, aiming for profitability by mid-2026.

Raiden Resources has expanded its Phase 2 drilling at the Vuzel Gold Project in Bulgaria, confirming significant gold mineralisation and increasing its stake to 75%. Meanwhile, the company retains full ownership of the Arrow Gold Project after a partner withdrawal.

Bellevue Gold Limited reported robust cash flows for Q2 2025, boosting its liquidity position and reducing debt significantly through an early principal repayment. The company ends the quarter with a strong cash balance, underpinning ongoing development activities.

Advanced Health Intelligence Ltd (AHI) reports robust commercial progress and strategic funding moves in Q1 2025 despite ongoing ASX trading suspension and recent NASDAQ delisting. Key partnerships and technology validations position the company for a strong global scale-up.

Raptis Group Limited reported a solid quarter ending June 2025, posting positive operating cash flow and bolstering its cash reserves to nearly $2 million. Significant investing outflows were offset by substantial financing inflows, positioning the company for future operational stability.

Bod Science Limited reports a dramatic reduction in half-year losses alongside revenue growth driven by a strategic shift to THC products. The company remains under a Deed of Company Arrangement with key corporate actions pending shareholder approval.